Non-profit website: free to use. No fees from patients, hospitals or doctors. Not an agency. · Free · Not an agencyLearn more
Medical oncology · Peking University Cancer Hospital · Beijing

Dr. Li Siming李思明

Associate Chief Physician

Summary compiled from public information, updated 18 Nov 2026. It has not been checked against the hospital website yet. Confirm details with the hospital before you travel.

Dr. Li Siming

Professional overview

Li Siming is an Associate Chief Physician in the Department of Urologic Oncology at Peking University Cancer Hospital, specializing in comprehensive treatment—including chemotherapy, targeted therapy, immunotherapy, and novel agents—for urogenital tumors and melanoma.

SpecialtyMedical oncology
Clinical titleAssociate Chief Physician
Academic rolesDoctoral Supervisor
DepartmentDepartment of Urologic Oncology
HospitalPeking University Cancer Hospital
CityBeijing

Areas of focus

Renal cell carcinoma
Urothelial carcinoma
Prostate cancer
Melanoma

Background

  • 2008Joined the Department of Renal Cancer and Melanoma, Peking University Cancer Hospital
  • 2013Received PhD in Oncology from Peking University
  • 2020Visiting Scholar at Massachusetts General Hospital, Harvard Medical School

Experience & recognition

  • Recipient of Peking University Top Ten Resident Physician award
  • Recipient of Youth Post Expert award at Peking University Cancer Hospital
  • Recipient of Outstanding Staff award at Peking University Cancer Hospital

Professional roles

  • Member, Renal Cancer Committee, Chinese Society of Clinical Oncology (CSCO)
  • Secretary, Rare Subtype Renal Cancer Working Group, Urogenital Tumor Committee, China Anti-Cancer Association (CACA-GU)
  • Secretary-General, Head and Neck Malignant Melanoma Committee, Beijing Anti-Cancer Association
  • Member, Thermal Therapy Committee, Beijing Anti-Cancer Association
  • Standing Committee Member, Sixth Academic Department (Research Translation), Tumor Prevention and Treatment Branch, Chinese Research Association of Geriatric Health Care
  • Young Editorial Board Member, Chinese Journal of Biomedical Engineering
  • Reviewer, Melanoma Research
  • Reviewer, Journal of Immunology Research

Frequently asked questions

What does Dr. Li Siming specialize in?

Comprehensive treatment—including chemotherapy, targeted therapy, immunotherapy, and new drug therapy—for urogenital tumors (renal cancer, urothelial carcinoma, prostate cancer, testicular cancer) and melanoma

Which hospital and department is Dr. Li Siming in?

Department of Urologic Oncology at Peking University Cancer Hospital

Sources

Dr. Li Siming has not reviewed this page. Request a correction or removal.